DCM
CO

DGS Capital Management’s Global Cord Blood Corporation CO Stock Holding History

DGS Capital Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-31,516
Closed -$121K – 235
2022
Q1 		$121K Sell
31,516
-2,930
-9% -$12.2K 0.07% 184
2021
Q4 		$144K Buy
+34,446
New +$146K 0.09% 157

Other funds holding CO

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DGS Capital Management's CO Position: Q2 2022 in Review

DGS Capital Management sold out of Global Cord Blood Corporation (CO) in Q2 2022, closing a stake of 31,516 shares — an estimated $121K sold.

DGS Capital Management first reported a position in CO in Q4 2021 and held it in 2 quarters. The position peaked at $144K in Q4 2021. 25 funds tracked by Wall St. Rank hold CO as of Q2 2022.

  • DGS Capital Management reported no remaining Global Cord Blood Corporation position as of Q2 2022 after selling out during the quarter.
  • DGS Capital Management sold 31,516 Global Cord Blood Corporation shares in Q2 2022, an estimated $121K.
  • DGS Capital Management first reported a position in Global Cord Blood Corporation in Q4 2021 and held it in 2 quarters.
  • DGS Capital Management's Global Cord Blood Corporation position peaked at $144K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2022.

Based on DGS Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.